Talis Biomedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	59.87	76.73	130.19	232.55	138.48	21.6
Cash & Short-Term Investments	59.87	76.73	130.19	232.55	138.48	21.6
Cash Growth	-39.04%	-41.06%	-44.02%	67.92%	541.01%	213.33%
Receivables	-	0.05	0.31	0.18	0.47	1.81
Prepaid Expenses	3.73	0.9	2.78	3.39	0.71	0.43
Restricted Cash	-	-	-	-	34.65	-
Other Current Assets	-	-	-	-	14.41	0.27
Total Current Assets	63.6	77.68	133.28	236.12	188.72	24.11
Property, Plant & Equipment	8.33	15.45	34.23	23.44	9.68	1.54
Other Long-Term Assets	0.77	1.54	1.78	6.28	-	0.09
Total Assets	72.7	94.67	169.29	265.83	198.41	25.73
Accounts Payable	3.79	1.34	3.77	5.12	4.91	1.57
Accrued Expenses	1.48	4.55	5.2	12.75	10.43	2.13
Current Portion of Leases	2.92	2.88	3.7	1.23	0.69	-
Other Current Liabilities	-	-	-	-	-	0.34
Total Current Liabilities	8.2	8.77	12.67	19.11	16.03	4.04
Long-Term Leases	15.88	16.79	29.88	12.75	-	-
Other Long-Term Liabilities	-	-	-	-	-	0.08
Total Liabilities	24.07	25.56	42.55	31.85	16.03	4.12
Common Stock	-	-	-	0	-	-
Additional Paid-In Capital	610.47	609.07	604.69	598.91	64.34	60.64
Retained Earnings	-561.85	-539.96	-477.95	-364.94	-172.91	-81.78
Total Common Equity	48.62	69.11	126.74	233.97	-108.57	-21.14
Shareholders' Equity	48.63	69.12	126.74	233.98	182.37	21.62
Total Liabilities & Equity	72.7	94.67	169.29	265.83	198.41	25.73
Total Debt	18.8	19.67	33.58	13.98	0.69	-
Net Cash (Debt)	41.07	57.06	96.61	218.57	137.79	21.6
Net Cash Growth	-47.23%	-40.93%	-55.80%	58.62%	537.80%	213.33%
Net Cash Per Share	22.55	31.40	53.66	144.71	974.78	150.68
Filing Date Shares Outstanding	1.82	1.82	1.79	1.78	1.71	0.14
Total Common Shares Outstanding	1.82	1.82	1.79	1.76	0.14	0.14
Working Capital	55.41	68.91	120.61	217.01	172.69	20.07
Book Value Per Share	26.68	37.93	70.95	132.90	-765.93	-149.89
Tangible Book Value	48.62	69.11	126.74	233.97	-108.57	-21.14
Tangible Book Value Per Share	26.68	37.93	70.95	132.90	-765.93	-149.89
Machinery	-	14.72	13.9	8.99	4.72	2.96
Construction In Progress	-	-	0.98	4.72	6.58	-
Leasehold Improvements	-	1.25	1.25	0.81	0.81	0.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.